Dergiler / Turkish Journal of Pediatrics / 2019 / Cilt: 61 - Sayı: 5

Acute ophthalmoparesis and persistent mydriasis: expanding the clinical spectrum of anti-GQ1b positive cranial neuropathy in a 5.5-year-old girl

Sayfa
794–797
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Our case shows the expanding clinicalspectrum of anti-GQ1b positive cranial neuropathy as early-onset AO andprolonged mydriasis more than one year.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Acute ophthalmoparesis without ataxia (AO) is an atypical form of MillerFisher syndrome (MFS) and is rare in children.
📊
Temel Bulgular & Veri:Anti-GQ1b antibodies canbe detected in patients with AO, as in MFS.
💡
Sonuç & Katkı:Our case shows the expanding clinicalspectrum of anti-GQ1b positive cranial neuropathy as early-onset AO andprolonged mydriasis more than one year.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Acute ophthalmoparesis without ataxia (AO) is an atypical form of MillerFisher syndrome (MFS) and is rare in children. Anti-GQ1b antibodies canbe detected in patients with AO, as in MFS. A 5.5-year-old girl had totalophthalmoparesis, blurred vision, ptosis, diplopia and mydriasis non-reactiveto light or near stimuli with preserved consciousness and deep tendon reflexes.She had no ataxia. Cerebrospinal fluid (CSF) examination and cranial MRIwere normal. Serum antiGQ1b antibodies were positive. She was diagnosedwith AO and intravenous Immunoglobulin (IVIG) was ordered, 400 mg/kg/day, for 5 days. Ophthalmoparesis and blurred vision improved in a fewweeks. At the end of the first year, mydriasis still persisted, but improvedand became responsive to near stimuli. Pupillary involvement may be seenin approximately 50% of MFS patients, and improvement in a few weeks ormonths has been reported in adults. Our case shows the expanding clinicalspectrum of anti-GQ1b positive cranial neuropathy as early-onset AO andprolonged mydriasis more than one year.

🔖

Bu Makaleye Atıf Yap

GÜNEŞ, A. S., GENÇ, H. M., YALÇIN, E. U., YILMAZ, V., DİRESKENELİ, G. S., KARA, B. (2019). Acute ophthalmoparesis and persistent mydriasis: expanding the clinical spectrum of anti-GQ1b positive cranial neuropathy in a 5.5-year-old girl. Turkish Journal of Pediatrics, Cilt: 61 - Sayı: 5, 794–797. https://ajindex.com/articles/412013

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Fisher M. An unusual variant of acute idiopathic polyneuritis. N Engl J Med 1956; 255: 57-65
  2. Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve 2007; 36: 615- 627
  3. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001; 70: 50-55
  4. Lee SH, Lim GH, Kim JS, et al. Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody. Neurology 2008; 71: 426-429
  5. Fukami Y, Wong AHY, Funakoshi K, Safri AY, Shahrizaila N, Yuki N. Anti-GQ1b antibody syndrome. Eur J Neurol 2016; 23: 320-326
  6. Sato H, Naito K, Hashimto T. Acute isolated bilateral mydriasis. Case reports and review on the literature. Case Rep Neurol 2014; 6: 74-77
  7. Liu JX, Willison HJ, Pedrosa-Domellöf F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci 2009; 50: 3226-3232
  8. Nagaoka U, Kato T, Kurita K, et al. Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome. Neurology 1996; 47: 1601-1602
  9. Kaymakamzade B, Selcuk F, Koysuren A, Colpak AI, Mut SE, Kansu T. Pupillary involvement in Miller Fisher syndrome. Neuro-Ophthalmol 2013; 37: 111- 115
  10. Nitta T, Kase M, Shinmei Y, Yoshida K, Chin S, Ohno S. Mydriasis with light-near dissociation in Fisher’s syndrome. Jpn J Ophthalmol 2007; 51: 224-227.